PF-06282999
- Generic Name
- PF-06282999
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C13H12ClN3O3S
- CAS Number
- 1435467-37-0
- Unique Ingredient Identifier
- YO3O4Q2NC8
- Background
Pf 06282999 is under investigation in clinical trial NCT01626976 (A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects).
- Associated Conditions
- -
- Associated Therapies
- -
A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model
- First Posted Date
- 2013-10-18
- Last Posted Date
- 2016-08-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 23
- Registration Number
- NCT01965600
- Locations
- 🇺🇸
(Drug Shipment Address ONLY) Duke University Health Systems (DUHS) Investigational Drug Services, Durham, North Carolina, United States
🇺🇸Duke Clinical Research Unit, Durham, North Carolina, United States
A Study To Test The Safety, Amount And Effects Of PF-06282999 In Healthy Overweight Adults And A Study To Test The Effects Of PF-06282999 On The Amount Of The Approved Drug, Midazolam, In Healthy Adults
- First Posted Date
- 2012-10-15
- Last Posted Date
- 2013-07-31
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 69
- Registration Number
- NCT01707082
- Locations
- 🇧🇪
Pfizer Investigational Site, Brussels, Belgium
A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects
- First Posted Date
- 2012-06-25
- Last Posted Date
- 2013-03-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 42
- Registration Number
- NCT01626976
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath